Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Unknown 1Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Leukemia, Myeloid, Acute 44Precursor Cell Lymphoblastic Leukemia-Lymphoma 30Myelodysplastic Syndromes 26Lymphoma, Non-Hodgkin 20Hematologic Neoplasms 20Lymphoma 19Multiple Myeloma 18Recurrence 15Lymphoma, B-Cell 15Lymphoma, Large B-Cell, Diffuse 13Leukemia, Lymphocytic, Chronic, B-Cell 12Burkitt Lymphoma 12Breast Neoplasms 11Ovarian Neoplasms 10Lymphoma, Follicular 10Pancreatic Neoplasms 9Leukemia, Myelomonocytic, Chronic 9Neoplasm Metastasis 8Myeloproliferative Disorders 8Melanoma 8Lymphoma, Mantle-Cell 7Lymphoma, B-Cell, Marginal Zone 7Leukemia, Biphenotypic, Acute 7Leukemia 7Hodgkin Disease 7Glioblastoma 7Carcinoma, Non-Small-Cell Lung 7Triple Negative Breast Neoplasms 6Stomach Neoplasms 6Osteosarcoma 6

Interventions

Magnetic Resonance Spectroscopy 3aldesleukin 2Paclitaxel 2Nivolumab 2Ifosfamide 2Cisplatin 2Adoptive Transfer 2toripalimab 1pembrolizumab 1niraparib 1lenvatinib 1fludarabine 1enfortumab vedotin 1dostarlimab 1cabozantinib 1Ultrasonography 1Specimen Handling 1Sentinel Lymph Node Biopsy 1Magnetic Resonance Imaging 1Ipilimumab 1Fluorodeoxyglucose F18 1FAPI-46 1Cyclophosphamide 1CTLA-4 Antigen 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Penile Neoplasms × fludarabine × Clear all
NCT05952947 2024-02-02

HRYZ-T101 Injection for HPV18 Positive Solid Tumor

HRYZ Biotech Co.

Phase 1 Recruiting
32 enrolled
GastrointestinalGenitourinaryGynecologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Anus Neoplasms, Uterine Cervical Neoplasms, Penile Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡